Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix Reports Q1 2020 Financial Results

GlobeNewswire April 23, 2020

NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia

GlobeNewswire April 16, 2020

NeuroMetrix, Inc. Announces Date for First Quarter 2020 Financial Results Conference Call

GlobeNewswire April 16, 2020

NeuroMetrix Announces 2020 Annual Meeting of Shareholders Will Be Held in Virtual Meeting Format Only

GlobeNewswire April 10, 2020

NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update

GlobeNewswire March 11, 2020

NeuroMetrix Reports Clinical Studies Recently Published on DPNCheck®

GlobeNewswire March 5, 2020

NeuroMetrix Reports Scientific Presentations at the American Academy of Pain Medicine 2020 Annual Meeting

GlobeNewswire February 25, 2020

NeuroMetrix Reports Q4 and Full Year 2019 Financial Results

GlobeNewswire January 27, 2020

NeuroMetrix, Inc. 2019 Financial Conference Call Rescheduled to Monday January 27, 2020

GlobeNewswire January 22, 2020

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2019 Financial Results Conference Call

GlobeNewswire January 17, 2020

NeuroMetrix Announces One-for-Ten Reverse Split

GlobeNewswire November 18, 2019

NeuroMetrix Reports Q3 2019 Financial Results

GlobeNewswire October 17, 2019

NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy

GlobeNewswire October 15, 2019

NeuroMetrix, Inc. Announces Date for Third Quarter 2019 Financial Results Conference Call

GlobeNewswire October 10, 2019

NeuroMetrix Reports Q2 2019 Financial Results

GlobeNewswire July 18, 2019

NeuroMetrix, Inc. to Host Earnings Call

Accesswire July 18, 2019

NeuroMetrix, Inc. Announces Date for Second Quarter 2019 Financial Results Conference Call

GlobeNewswire July 11, 2019

NeuroMetrix Provides Strategic Update

GlobeNewswire June 27, 2019

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

GlobeNewswire May 21, 2019

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

GlobeNewswire May 7, 2019